Clinical Trial Update: A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis [Phase 3]

View source ↗

Summary

A phase 3 pilot trial investigated mirabegron for symptoms in patients with interstitial cystitis, but the study was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Interstitial Cystitis

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Philadelphia Urosurgical Associates | Conditions: Cystitis, Interstitial | Phase 3 | Status: TERMINATED | Results posted: 2019-12-03